Work

LKB1 deficiency sensitizes cancer cells to oxidative stress

Year: 2015
Type: article
Abstract: Increased oxidative stress is a common feature of cancer cells. Uncontrolled proliferation, in fact, requires a profound metabolic remodelling, accompanied by altered redox status. Moreover, reactive oxygen species (ROS) are involved in cell signalling, tumor growth and metastasis. Recent studies suggest that increased oxidative stress in cancer cells could be exploited for therapeutic purposes. Understanding biochemical mechanisms involved in ROS generation and maintenance of the cellular antioxidant potential raises the possibility of therapeutic targeting these pathways. In our study, we investigated the role of LKB1/AMPK pathway in response to oxidative stress. LKB1 is a serine threonine kinase whose germ-line mutations are associated with the Peutz-Jeghers syndrome and somatically mutated in certain tumor types, including non-small cell lung cancer (NSCLC) and cervical carcinoma. Through the activation of AMP-activated protein kinase (AMPK), LKB1 modulates both anabolic and catabolic metabolic processes. We observed that LKB1 reconstitution in LKB1-deficient cancer cells significantly reduced expression of NADPH oxidase 1 (NOX1), a ROS-producing enzyme. LKB1+ cells showed reduced endogenous oxidative stress and increased resistance to exogenous oxidative stress, induced by hydrogen peroxide, cisplatin or irradiation, compared to LKB1- cells. Moreover, we observed that AMPK inhibition sensitized LKB1+ cells to oxidative stress, whereas NOX1 inhibition reduced ROS generation and increased resistance to exogenous oxidative stress. In lung cancer samples, LKB1 mutations were strongly associated with loss of LKB1 protein but the LKB1 status was not associated with response to bevacizumab and platinum-based chemotherapy in advanced NSCLC patients. Overall, these results indicate that LKB1, via the activation of AMPK and the down-regulation of NOX1, confers resistance to oxidative stress and impairs response of cancer cells to some chemotherapeutics and irradiation in vitro.
Language: English
Open Access status: green
OpenAlex ID: W2207471308
FWCI:
Cites: 149
Cited by:
Related to: 10